UBS analyst Henri Patricot adjusted the price target for BP Plc. (NYSE:BP:LN) (NYSE: BP), increasing it to GBP5.25 from the previous GBP5.00, while reaffirming a Buy rating on the shares. The ...

We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...

Shopify shares actionable small business tips from expert entrepreneurs, including how to find success in your marketing, ...

The round was led by Smedvig Ventures, with investment from Expon Capital and Motier Ventures as well as business angels With the funding, MarketLeap will ramp up AI-driven automation in the platform, ...

Bridging strategy and execution is the final part of laying out any road map to success. The keystone along the ...

Organizations face a dual challenge: creating physical spaces that support the processing power required for AI solutions ...

With Fevertree still priced at growth stock valuations, it pays to be cautious.

You can hear investors screaming about how overvalued Palantir (PLTR) stock is after this week’s earnings report. Heck, investors were telling the same story a year ago, but the stock is still ...

Liam Gallagher responds to Oasis fans seeing their tickets cancelled, phone users have been warned to check half-term roaming charges - and we're relaunching our Women in Business series, where we ...